Information and Resources

Information and resources to support Medicines Optimisation activities across care settings and practice areas during COVID-19

Out-of-Hospital Care and COVID-19

Resources and tools to support Medicines Optimisation activities out-of-hospital during COVID-19

Transfer of care and COVID-19

Resources and tools to support transfer of care between care settings during COVID-19

Injectable medicines and COVID-19

Resources and tools to support best use of injectable medicines during COVID-19

Drug monitoring and COVID-19

Resources to support changes to drug monitoring requirements during COVID-19

Specialty Guidance

Summarised Medicines Optimisation COVID-19 recommendations from professional bodies and national organisations.

Summary of COVID-19 medicines guidance: Learning disabilities

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities. Our advice…

Summary of COVID-19 medicines guidance: Diabetes

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Allergy and immunology

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and allergy and immunology conditions.…

Summary of COVID-19 medicines guidance: Stroke

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and stroke. Our advice is…

Summary of COVID-19 medicines guidance: Mental health and illness

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and mental health and illness.…

All resources

Summary of COVID-19 medicines guidance: Learning disabilities

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities. Our advice…

Summary of COVID-19 medicines guidance: Diabetes

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Allergy and immunology

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and allergy and immunology conditions.…

Summary of COVID-19 medicines guidance: Stroke

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and stroke. Our advice is…

Summary of COVID-19 medicines guidance: Mental health and illness

12 April 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and mental health and illness.…